...
首页> 外文期刊>Laryngo- rhino- otologie >Reconstruction of large conjunctival and orbital defects with preserved amniotic membrane [Rekonstruktion von gro?en oberfl?chlichen Defekten der Konjunktiven und der Orbita mit Amnionmembran]
【24h】

Reconstruction of large conjunctival and orbital defects with preserved amniotic membrane [Rekonstruktion von gro?en oberfl?chlichen Defekten der Konjunktiven und der Orbita mit Amnionmembran]

机译:保留羊膜修复大结膜和眼眶缺损

获取原文
获取原文并翻译 | 示例
           

摘要

Smoking Behaviour after Laryngectomy Background: Tobacco smoking is an important risk factor for laryngeal cancer. Aim of this study was to investigate the prevalence of smoking and to identify factors that can promote tobacco abstinence. Patients and Methods: In a multi-centre cross-sectional study, 187 patients after laryngectomy were surveyed regarding their smoking behaviour. Instruments used were the questionnaire Quality of Life after Laryngectomy (Ackerstaff & Hilgers) and the Questionnaire of Health Behaviour (Fragebogen zur Erfassung des Gesundheitsverhaltens, Dlugosch & Krieger). Results: Life time prevalence of tobacco smoking was 89%, whereas current prevalence was only 6%. None of the laryngectomees believed tobacco consumption to be safe. 24% thought that their tumour was caused mainly by smoking, although the current prevalence of smoking was not related to that number. 74% of all ex-smokers had stopped smoking at the time of the laryngectomy. Conclusions: Only a small fraction of laryngectomised patients do smoke several years after the operation. Anti-tobacco interventions should therefore be focused on high risk persons, not on the entire patient population.
机译:喉切除术后的吸烟行为背景:吸烟是喉癌的重要危险因素。这项研究的目的是调查吸烟率,并找出可以促进戒烟的因素。患者和方法:在一项多中心的横断面研究中,对187例喉切除术后的患者的吸烟行为进行了调查。所使用的工具是喉切除术后的生活质量问卷(Ackerstaff&Hilgers)和健康行为问卷(Fragebogen zur Erfassung des Gesundheitsverhaltens,Dlugosch&Krieger)。结果:吸烟终生患病率为89%,而目前的患病率仅为6%。没有一个喉头切除术者认为食用烟草是安全的。 24%的人认为他们的肿瘤主要是由吸烟引起的,尽管当前吸烟率与该数字无关。所有的前吸烟者中有74%在喉切除术时已戒烟。结论:只有少数喉切除手术的患者术后数年会吸烟。因此,反烟草干预措施应针对高危人群,而不是整个患者人群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号